14-day Premium Trial Subscription Sign Up For FreeGet Free

Oncology Pharma Inc. Stock Forecast PINK:ONPH

$10.20 (0%)

Volume: 0

Closed: Oct 25, 2021

Hollow Logo Score: -2.812

Oncology Pharma Inc. Stock Forecast

$10.20 (0%)

Volume: 0

Closed: Oct 25, 2021

Score Hollow Logo -2.812
Which way will ONPH go? Request

ONPH Stock Risk

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 19.80%

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 52 and the stock is currently not being overbought or oversold

Oncology Pharma Inc. stock upgraded to Sell Candidate.
(Updated on Oct 25, 2021)


Sell candidate since 2021-10-25

No changes to the price of Oncology Pharma Inc. stock on the last trading day (Monday, 25th Oct 2021). During the day the stock fluctuated 0% from a day low at $10.20 to a day high of $10.20. The price has risen in 6 of the last 10 days and is up by 40.88% over the past 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -47.58% during the next 3 months and, with a 90% probability hold a price between $2.33 and $8.18 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, October 22, 2021, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oncology Pharma Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $13.04 and $11.87. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $9.35 and $9.20. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma Inc. finds support just below today's level at $9.35. If this is broken, then the next support from accumulated volume will be at $9.20 and $7.77.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 19.80%

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Oncology Pharma Inc. stock A Buy?

Oncology Pharma Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.812

Predicted Opening Price for Oncology Pharma Inc. of Tuesday, October 26, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price October 26, 2021 Current price
$10.20 $10.20 (Undervalued)
Sell Candidate Upgraded

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 19.80 %
Overall Risk: Very High High Medium Low Very Low
Volatility
19.80 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $10.94
Price: $10.20
Support: $9.35

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 10.20 .
10.20 .
10.20 .
Current price: 10.20
Support 10.20 .
10.20 .
10.20 .

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 12.00 17.65 %
11.35 11.27 %
10.94 7.25 %
Current price 10.20
Support 9.35 -8.33%
9.20 -9.80%
7.77 -23.82%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT